Full Press Release Details
New Phase 2 Data Analysis For Crenezumab Presented at Global Alzheimer s Conference Provides Strong Evidence For Engagement of The Principle Abeta Target.
ACIU
New Phase 2 Data Analysis For Crenezumab Presented at Global Alzheimer s Conference Provides Strong Evidence For Engagement of The Principle Abeta Target
Key Takeaway: New Phase 2 Data Analysis For Crenezumab Presented at Global Alzheimer s Conference Provides Strong Evidence For Engagement of The Principle Abeta Target